Literature DB >> 26349950

Albuminocytologic Dissociation in Posterior Reversible Encephalopathy Syndrome.

Sudhir Datar1, Tarun D Singh2, Jennifer E Fugate2, Jay Mandrekar3, Alejandro A Rabinstein2, Sara Hocker2.   

Abstract

OBJECTIVES: To describe cerebrospinal fluid (CSF) findings in patients with posterior reversible encephalopathy syndrome (PRES) and to study its association with vasogenic edema. PATIENTS AND METHODS: Retrospective review of 73 consecutive prospectively collected adults diagnosed with PRES from January 1, 2000, through December 31, 2014, who underwent lumbar puncture.
RESULTS: Seventy-three patients (mean age, 51±17 years), were included in the analysis; of these, 50 (69%) were women. The most common causes for PRES were hypertension (n=61 [84%]) and immunosuppression (n=22 [30%]). Renal failure was present in 42 (58%) patients. The median interval between clinical onset of PRES and CSF analysis was 1 day (interquartile range [IQR], 0-2 days). The median opening pressure was 23 cm H2O or 17 mm Hg (IQR, 18-28 cm H2O or 13-21 mm Hg), although it was available in only 27 patients. The median CSF protein level was 58 mg/dL (IQR, 44-81 mg/dL; normal value, <35 mg/dL). The median CSF protein level was higher in patients with more extensive vasogenic edema. The median white blood cell count was 1 cell/μL (IQR, 1-2 cells/μL).
CONCLUSION: Elevated CSF protein level without CSF pleocytosis commonly occurs in patients with PRES and is directly associated with the extent and topographical distribution of cerebral edema. Although mild CSF pleocytosis can also occur, it is an uncommon finding and may prompt consideration for further diagnostic testing.
Copyright © 2015 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26349950     DOI: 10.1016/j.mayocp.2015.07.018

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  13 in total

1.  Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome.

Authors:  Pierre R Bourque; Ari Breiner
Journal:  Neurohospitalist       Date:  2019-05-05

2.  Authors' Reply to Drs Bourque and Breiner, Re: Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome.

Authors:  Colin A Ellis; Ramani Balu
Journal:  Neurohospitalist       Date:  2019-06-12

Review 3.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

4.  Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome: Implications of Elevated Protein and Pleocytosis.

Authors:  Colin A Ellis; Andrew C McClelland; Suyash Mohan; Emory Kuo; Scott E Kasner; Cen Zhang; Pouya Khankhanian; Ramani Balu
Journal:  Neurohospitalist       Date:  2018-09-27

5.  Guillain-Barré syndrome and posterior reversible leukoencephalopathy syndrome: a rare association.

Authors:  Stuti Joshi; David Prentice; Jolandi van Heerden; Thomas Chemmanam
Journal:  BMJ Case Rep       Date:  2020-04-20

Review 6.  Posterior reversible encephalopathy syndrome.

Authors:  Marlene Fischer; Erich Schmutzhard
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

7.  Rapid intracranial pressure drop as a cause for posterior reversible encephalopathy syndrome: Two case reports.

Authors:  Ryoko Niwa; Soichi Oya; Takumi Nakamura; Taijun Hana; Toru Matsui
Journal:  Surg Neurol Int       Date:  2017-06-05

8.  Central-Variant Posterior Reversible Encephalopathy Syndrome with Albuminocytologic Dissociation.

Authors:  Sang-Woo Lee; Seung-Jae Lee
Journal:  Case Rep Neurol       Date:  2018-02-02

9.  Causes of albuminocytological dissociation and the impact of age-adjusted cerebrospinal fluid protein reference intervals: a retrospective chart review of 2627 samples collected at tertiary care centre.

Authors:  John Alexander Brooks; Christopher McCudden; Ari Breiner; Pierre R Bourque
Journal:  BMJ Open       Date:  2019-02-13       Impact factor: 2.692

10.  Cerebellar Parieto-occipital Posterior Reversible Encephalopathy Syndrome and Cerebral Metamorphopsia Associated with Asymptomatic Atrial Septum Vegetation and Renal Disease: Case Report.

Authors:  Arash Ghaffari-Rafi; Anthony C Netzel; Madeline Prat; Daniel T Miles
Journal:  Am J Case Rep       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.